🇺🇸 FDA
Patent

US 8816058

Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof

granted A61KA61K2039/505A61K38/1774

Quick answer

US patent 8816058 (Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof) held by VACCINEX, INC. expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VACCINEX, INC.
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K38/1774, A61K39/0001, A61K39/3955